Over 30% of deaths in Hong Kong are caused by cancer(5). The top five fatal cancers are lung cancer, colon cancer, liver cancer, breast cancer and pancreatic cancer(5).
Nearly 20% of cancer patients give up treatment because they could no longer afford it. For instance, targeted therapy for lung cancer amounts to as high as $50,000 monthly(7) while full treatment for colon cancer at private hospitals costs $1.3 million(6).
Prolonged waiting time for treatments could lead to poorer health outcomes. The waiting time for treatment at public hospitals ranges from several weeks to over 2 years(8)
Coverage
Medical Services Incurred from Covered Cancer(s) — payable for the actual expenses for necessary Medical Services which are incurred from Covered Cancer(s).
Area Cover
Worldwide
Claim Method
Reimbursement—
1. We will reimburse the actual medical expenses arising from Covered Cancer(s) according to the benefit items and limits listed in the table below.
2. Same Eligible Expenses item will only be reimbursable under one benefit item.
3. If the Insured is entitled to a refund of all or part of such expenses from other source(s), we will only be liable for an amount in excess of the amount recovered from such other source(s).
Waiting Period
90 days — Any Cancer occurring during the first 90 days after Policy Effective Date is not covered.
Benefit Limit
Cancer Fighter 100
Cancer Fighter 200
Cancer Fighter 300
Compassionate Death Benefit
$10,000
Phase
Diagnostic
Treatment
Treatment
Treatment / Terminal Cancer
Treatment / Terminal Cancer/ Recovery
Recovery
Terminal Cancer
Others
15 days to age 65
Lifelong - yearly guaranteed renewal
HKD
The information above is for reference only, for more details please go to
1. Product terms & conditions(Cancer-100/Cancer-200/Cancer-300)
Items (a)-(i) have restricted conditions
Items (o) - (u) have a compensation limit
Listed items are for reference only, for all details and terms & conditions:Key Product Risks and Exclusion
Listed items are for reference only, for all details and terms & conditions:Key Product Risks and Exclusion